JapanWaterfall“That’s agreatquestion”STR“Cure”OnoPharmaceuticalsExecutive says thatwe are notdivulging details ofcontracts/contractsare confidential“Discount”AbbVie4week(s)VA“Congratson a greatquarter”Analystmakesexecutiveslaugh“PriceWar”PrEPRanexaor RiverPCIHarvoni ismispronouncedAnalysts aretold TWICE thatthere is onlyone questionper analystAnalystonly asksonequestionA femaleanalystasks aquestionAnalystasks 3questionsExpressScripts(or ESI)/SteveMiller“…and myotherquestionis”SimtuzumabJapanWaterfall“That’s agreatquestion”STR“Cure”OnoPharmaceuticalsExecutive says thatwe are notdivulging details ofcontracts/contractsare confidential“Discount”AbbVie4week(s)VA“Congratson a greatquarter”Analystmakesexecutiveslaugh“PriceWar”PrEPRanexaor RiverPCIHarvoni ismispronouncedAnalysts aretold TWICE thatthere is onlyone questionper analystAnalystonly asksonequestionA femaleanalystasks aquestionAnalystasks 3questionsExpressScripts(or ESI)/SteveMiller“…and myotherquestionis”Simtuzumab

Q4'14 Earnings Call Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Japan
  2. Waterfall
  3. “That’s a great question”
  4. STR
  5. “Cure”
  6. Ono Pharmaceuticals
  7. Executive says that we are not divulging details of contracts/contracts are confidential
  8. “Discount”
  9. AbbVie
  10. 4 week(s)
  11. VA
  12. “Congrats on a great quarter”
  13. Analyst makes executives laugh
  14. “Price War”
  15. PrEP
  16. Ranexa or River PCI
  17. Harvoni is mispronounced
  18. Analysts are told TWICE that there is only one question per analyst
  19. Analyst only asks one question
  20. A female analyst asks a question
  21. Analyst asks 3 questions
  22. ExpressScripts (or ESI)/Steve Miller
  23. “…and my other question is”
  24. Simtuzumab